Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
FLPET (R+D)
Línea
Nuclear Medicine
Sublínea
PET Radiopharmaceuticals
FLPET (R+D)
Nuclear Medicine
FLPET (R+D)
Name:
FLPET (R&D)
Active Principle:
3´-DEOXI-3-(18F)-FLUORTHIMIDINE
Therapeutic Action:
It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness of tumors such as Astrocytoma, glioblastoma multiforme, medulloblastoma, oligogastrocytoma, ganglioma, lung cancer, colorectal carcinoma, malignant melanoma, Non-Hodgkin’s lymphoma, breast cancer and pancreatic ductal adenocarcinoma.
RELATED PRODUCTS
-
123I MIBG BACON (R&D)
123I MIBG BACON (R&D)It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest...